The effectiveness and cost-effectiveness of biomarkers for the prioritisation of patients awaiting coronary revascularisation: a systematic review and decision model.
Hemingway H, Henriksson M, Chen R, Damant J, Fitzpatrick N, Abrams K, Hingorani A, Janzon M, Shipley M, Feder G, Keogh B, Stenestrand U, McAllister K, Kaski JC, Timmis A, Palmer S, Sculpher M.
Hemingway H, et al.
Health Technol Assess. 2010 Feb;14(9):1-151, iii-iv. doi: 10.3310/hta14090.
Health Technol Assess. 2010.
PMID: 20184812
Free article.
Review.